Catalog Advanced Search

Search by Categories
Search by Format
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • 2021 ACCP Virtual Journal Club Webinar-November | Effect of Hepatic Impairment on Cobimetinib Pharmacokinetics: The Complex Interplay Between Physiological Changes and Drug Characteristics-LIVE

    Contains 3 Component(s) Includes a Live Web Event on 11/17/2021 at 2:00 PM (EST)

    Cobimetinib is a kinase inhibitor indicated for use in combination with vemurafenib for treatment of unresectable/metastatic melanoma with specific BRAF mutations. Cobimetinib is extensively metabolized in liver; thus, patients with hepatic impairment (HI) might have increased cobimetinib exposure. By attending this educational activity, you will learn about the impact of HI on the pharmacokinetics (PK) and safety of cobimetinib.

    2021 ACCP Virtual Journal Club Webinar: Effect of Hepatic Impairment on Cobimetinib Pharmacokinetics: The Complex Interplay Between Physiological Changes and Drug Characteristics - LIVE

    Live webinar: November 17, 2021 from 2:00 - 3:00 PM ET 

    On-demand webinar recording: November 17, 2021 to November 17, 2024

    Why is this article important to your practice? 

    Cobimetinib is a kinase inhibitor indicated for use in combination with vemurafenib for treatment of unresectable/metastatic melanoma with specific BRAF mutations. Cobimetinib is extensively metabolized in liver; thus, patients with hepatic impairment (HI) might have increased cobimetinib exposure. By attending this educational activity, you will learn about the impact of HI on the pharmacokinetics (PK) and safety of cobimetinib. 

    Target Audience:

    Interprofessional team of Physicians, Pharmacists, PhDs, Nurse Practitioners and Physician Assistants.

    Sravanthi Cheeti, MS,

    Scientist

    Genentech Inc

    Sravanthi Cheeti’s focus is on clinical drug development, specifically on clinical pharmacology, which includes understanding the pharmacokinetics and pharmacodynamics of a drug in humans and how these and other factors relate to the clinical efficacy and safety of the drug. She has 14 years of industrial experience in clinical pharmacology. During this time, she has supported several oncology and neuroscience programs. She has developed clinical pharmacology strategies, including dose/regimen selection for Phase I - III studies and clinical pharmacology assessments to inform clinical protocols and label updates.She played a key role in determining appropriate dose and dose adjustments for special populations (e.g. pediatric, organ impairment, ethnicity, etc.), drug-drug interaction assessments, material bridging, and food effect assessments.

    Luna Musib, PhD

    Executive Director

    Gilead Sciences Inc

    Dr. Musib has over 21 years of experience in the field of Clinical Pharmacology.  She has experience in early clinical development as well as late stage development including successful filing of NDAs.  She has a strong passion for clinical pharmacology and works cross functionally to incorporate clinical pharmacology in drug development related to dose optimization, biopharmaceutics, drug interactions and incorporating modeling and simulation for decision making and to support drug approval.  She has received her PhD from University of Minnesota, following which she was a fellow in clinical pharmacology at University of Minnesota in the Department of Experimental and Clinical Pharmacology.  Subsequently, she has worked at Eli Lilly, Genentech, and Gilead sciences.  She currently is VP of Clin Pharmacology at Arrivent Biopharma.

  • ACCP Webinar | How to be a Great Journal Peer Reviewer

    Contains 2 Component(s)

    Presented by: Joseph S. Bertino Jr., PharmD, FCP, FCCP, Editor-in-Chief, The Journal of Clinical Pharmacology and David J. Greenblatt MD, FCP, Editor-in-Chief Clinical Pharmacology in Drug Development. This webinar provides professional training on performing scientific journal manuscript peer reviews.

    ACCP Webinar - How to be a GREAT Journal Peer Reviewer

    Why is this article important to your practice? 

    At the completion of this webinar participants will have a strong understanding and the skills to properly review a scientific manuscript, a professional competency applicable to journal peer reviewing across professions. Topics to be covered include: why one should serve as peer reviewer; the purpose of manuscript reviews; aspects of a great review; when to decline a review; confidentiality; a technical guide for reviews for each section of the manuscript; and writing the review.  

    Target Audience: 

    Researchers, Physicians, Pharmacists, and other professionals requiring training in the professional competencies of peer reviewing. 

    Learning Objectives: 

    After completing this activity, the learner will be able to:

    1. Describe why the peer review process is important;
    2. Explain how to review various sections of a scientific manuscript;
    3. Identify elements of writing a review that will be of benefit to the authors and to the Editor of the Journal.



    Joseph S. Bertino, Jr, PharmD, FCP, FCCP

    Editor-in-Chief

    Bertino Consulting

    Dr. Joseph S. Bertino is currently a Principal at Bertino Consulting. He is an Associate Professor of Pharmacology at the College of Physicians and Surgeons, Columbia University, and an Adjunct Associate Professor at the University at Buffalo School of Pharmacy.  He is also an Honorary Professor, Hanoi University of Pharmacy and a Distinguished Professor of the Hai Phong University of Medicine and Pharmacy. He has published over 100 original research papers, review articles and book chapters including work in the area of antimicrobial pharmacokinetics, pharmacodynamics and toxicity, drug-drug interactions, general clinical pharmacology, vaccine pharmacology and the application of pharmacogenetics and pharmacogenomics to the drug development process. He serves as the Editor-in-Chief of The Journal of Clinical Pharmacology.

    David J. Greenblatt, MD

    Professor

    Tufts Univ School of Medicine

    Dr. David J. Greenblatt holds the Louis Lasagna, MD, Endowed Professorship at Tufts University School of Medicine, in the Department of Immunology, and is a Senior Faculty Member in the Graduate Program in Pharmacology & Experimental Therapeutics at the Sackler School of Graduate Biomedical Sciences at Tufts University. He also holds appointments as Professor of Psychiatry, Medicine and Anesthesia. He has previously served as Chair of the Department of Pharmacology and Experimental Therapeutics, Program Director and Associate Program Director of the institution’s Clinical/Translational Research Center (formerly the General Clinical Research Center) and Chair of the Institutional Review Board. He is Editor-in-Chief of Clinical Pharmacology in Drug Development, a journal of the American College of Clinical Pharmacology. He also is Co-Editor-in-Chief, with Dr. Richard I. Shader, of the Journal of Clinical Psychopharmacology.

  • 2021 ACCP Annual Meeting | Post-event Self-assessment-WORKSHOPS

    Contains 6 Component(s), Includes Credits

    Thank you for attending the 2021 ACCP Annual Meeting Pre-meeting Workshop(s). Please complete the Survey Monkey course evaluation for each workshop you attended and then return to this page to complete a self-assessment of your post-course knowledge. After completing the self-assessment, be sure to claim and print your certificate for the course. As with any educational event, please only complete self-assessments and claim certificates for the workshops which you attended.

    The 2021 Annual Meeting Pre-meeting Workshops Self-assessment & CE Certificates program is available only to registered attendees. Please follow the individual course links in your attendee emails to complete your workshop evaluations (in Survey Monkey) and then return to this page to complete a self-assessment of your post-course knowledge. There is no minimum score to pass. After completing the self-assessment, be sure to claim and print your certificate for the workshop.  As with any educational event, please only complete self-assessments and claim certificates for the workshop(s) which you attended.

    The 2021 Annual Meeting Self-assessment & CE Certificates program is available only to registered attendees. Please follow the individual course links in your attendee emails to complete your workshop evaluations (in Survey Monkey) and then return to this page to complete a self-assessment of your post-course knowledge. There is no minimum score to pass. After completing the self-assessment, be sure to claim and print your certificate for the session.  As with any educational event, please only complete self-assessments and claim certificates for the sessions you attended.

  • 2021 ACCP Annual Meeting | Post-event Self-assessment-SYMPOSIA

    Contains 32 Component(s), Includes Credits

    Thank you for attending the 2021 ACCP Annual Meeting. Please complete the Survey Monkey course evaluation for each session you attended and then return to this page to complete a self-assessment of your post-course knowledge. After completing the self-assessment, be sure to claim and print your certificate for the course. As with any educational event, please only complete self-assessments and claim certificates for the sessions which you attended.

    The 2021 Annual Meeting Self-assessment & CE Certificates program is available only to registered attendees. Please follow the individual course links in your attendee emails to complete your workshop evaluations (in Survey Monkey) and then return to this page to complete a self-assessment of your post-course knowledge. There is no minimum score to pass. After completing the self-assessment, be sure to claim and print your certificate for the session.  As with any educational event, please only complete self-assessments and claim certificates for the sessions you attended.

    The 2021 Annual Meeting Self-assessment & CE Certificates program is available only to registered attendees. Please follow the individual course links in your attendee emails to complete your workshop evaluations (in Survey Monkey) and then return to this page to complete a self-assessment of your post-course knowledge. There is no minimum score to pass. After completing the self-assessment, be sure to claim and print your certificate for the session.  As with any educational event, please only complete self-assessments and claim certificates for the sessions you attended.

  • 2021 ACCP Virtual Journal Club August | Differential Binding of Sarilumab and Tocilizumab to IL-6Rα and Effects of Receptor Occupancy on Clinical Parameters- On Demand

    Contains 5 Component(s), Includes Credits

    Presented by: Christine Xu, PhD, Director, Translational Medicine & Early Development, Sanofi

    Differential Binding of Sarilumab and Tocilizumab to IL-6Rα and Effects of Receptor Occupancy on Clinical Parameters- On Demand

    ACCP Virtual Journal Club Webinars

    On Demand: August 18, 2021 to August 18, 2024

    See Handouts tab for Continuing Education information on IPCE credits.

    Why is this webinar important to you? 

    This webinar presents the bridging through pharmacokinetic/pharmacodynamic modeling the in vitro binding affinity to in vivo receptor occupancy and the potential association with clinical parameter improvements of sarilumab and tocilizumab in patients with rheumatoid arthritis. The study evaluated the in vitro binding of sarilumab and tociluzumab to interleukin (IL)-6Rα and inhibition of signaling and the association between IL-6Rα receptor occupancy and C-reactive protein (CRP) and potential clinical relevance of differences. 

    Target Audience
    Interprofessional team of Physicians, Pharmacists, PhDs, Nurse Practitioners and Physician Assistants.

    Learning Objectives
    After completing this activity, the learner will be able to: 

    1) Articulate the mechanism of action of sarilumab and tocilizumab and the downward physiologic effects;
    2) Differentiate the binding affinity of sarilumab and tocilizumab to IL-6Rα compared to placebo;
    3) Evaluate the expected response to CRP levels and the expected clinical response based on dosage and usage of sarilumab and tocilizumab.

    To receive credit, learners must attend the complete live webinar or view the complete on-demand webinar; complete a post-course assessment and evaluation.


  • ACCP Webinar | How to Make ACCP Member Benefits Work for YOU!-ON DEMAND

    Contains 1 Component(s)

    ACCP is a flagship society with a global reach and offers a wealth of benefits for its Members. Unfortunately, the full array of benefits available to Members and how best to leverage them may not be fully recognized. This webinar will inform Members, or those considering membership, of the diverse benefits available through ACCP. Using their own experiences, our Faculty Speakers will discuss Member Benefits and note the various professional milestones one can achieve through society involvement. Specific topics will include career advancement, educational opportunities, as well as gaining visibility and finding community in the field of clinical pharmacology. As the professional needs of ACCP Members tend to change throughout a career trajectory, our Faculty Speakers have been selected to represent viewpoints from early, mid and senior-level career stages. In addition to being recognized as leaders and experts in their disciplines, each of our Faculty Speakers has extensive experience within ACCP.

    ACCP Webinar - How to Make ACCP Member Benefits Work for YOU! - ON DEMAND

    Live webinar: June 16, 2021 from 2:00 - 3:30 PM ET 

    On-demand webinar recording:  June 16, 2021 to June 16, 2024

    Why is this article important to your practice? 

    ACCP is a flagship society with a global reach and offers a wealth of benefits for its Members. Unfortunately, the full array of benefits available to Members and how best to leverage them may not be fully recognized. This webinar will inform Members, or those considering membership, of the diverse benefits available through ACCP. Using their own experiences, our Faculty Speakers will discuss Member Benefits and note the various professional milestones one can achieve through society involvement. Specific topics will include career advancement, educational opportunities, as well as gaining visibility and finding community in the field of clinical pharmacology. As the professional needs of ACCP Members tend to change throughout a career trajectory, our Faculty Speakers have been selected to represent viewpoints from early, mid and senior-level career stages. In addition to being recognized as leaders and experts in their disciplines, each of our Faculty Speakers has extensive experience within ACCP.

    Kacey B. Anderson, PhD

    Senior Clinical Pharmacologist II

    Gilead Inc

    Dr. Anderson received her PhD in Pharmaceutical Sciences from the University of Pittsburgh. After graduating, she joined the Department of Clinical Pharmacology at Gilead Sciences in San Francisco, CA where she currently works as a Senior Clinical Pharmacologist II. In this role, Dr. Anderson is the lead clinical pharmacologist supporting several development programs for inflammation small molecules. Dr. Anderson joined ACCP in 2013 and is an active participant in the organization. She was diligently involved in the Student, Trainee & Early-stage Professional Committee since 2014 and led the committee as Co-chair from 2016 to 2019. More recently, she has served as a member of the Membership Committee (2019 – present) and the Annual Meeting Program Committee (2021 – present) and is currently participating in the Leadership Development Program. Furthermore, Dr. Anderson has also supported the society by manuscript submissions to the Clinical Pharmacology in Drug Development journal and attending and presenting at the Annual Meeting.

    Ayyappa Chaturvedula, PhD

    Associate Professor of Pharmacotherapy

    Univ of North Texas System Coll of Pharmacy

    Dr. Chaturvedula is currently working as Director, Clinical Pharmacology at Arcus Biosciences from June 2021. He also holds a position as an Associate Professor of Pharmacotherapy to teach in fully online Pharmacometrics certificate program at the UNT health science center at Fort Worth. He received bachelor’s in pharmacy from the University College of Pharmaceutical Sciences (UCPSC), Kakatiya University, India and PhD in Pharmaceutical Sciences from Mercer University, Atlanta, GA. He received advanced training in pharmacometrics as a visiting scientist in the Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California San Francisco, in association with the Center for Drug Development Science (CDDS). He has been awarded with 2020 Tanabe Young Investigator award by the American College of Clinical Pharmacology (ACCP).

    Michael W. Jann, PharmD

    Professor, Pharmacotherapy

    Univ of North Texas System Coll of Pharmacy

    Michael W. Jann, PharmD, FCP is Professor of Pharmacotherapy at the UNT SCP. Dr. Jann served as the UNTSCP Chair for the Dept of Pharmacotherapy from May 2013 to December 2017. Dr. Jann served as Chair for the Dept of Pharmacy Practice from July 2002 to May 2013 and held a cross appointment as Professor of Pharmaceutical Sciences at Mercer Univ Coll of Pharmacy & Health Sciences in Atlanta, GA. Dr. Jann held Mercer Univ’s Endowed Chair in Neuropsychopharmacology. The author or co-author of over 250 book chapters, peer-review articles and scientific abstracts. He is a member on the editorial boards of CNS Drugs, Journal of Pharmacy Practice, Molecular Diagnostics and Therapeutics, Consultant Pharmacist, The Scientific World Journal – Pharmacology Section and The Journal of Clinical Pharmacology

  • 2021 ACCP Virtual Journal Club May | Direct Oral to Parenteral Anticoagulants: Strategies for Inpatient Transition - ON DEMAND

    Contains 5 Component(s), Includes Credits

    Presented by: Chelsea N. Lopez, PharmD, BCCCP, Clinical Specialist, Houston Methodist Hosp

    Direct Oral to Parenteral Anticoagulants: Strategies for Impatient Transition- ON DEMAND

    ACCP Virtual Journal Club Webinars

    Live Session: Wednesday, May 19, 2021 from 2:00-3:00 PM ET

    On Demand: May 19, 2021 to May 19, 2024

    See Handouts tab for Continuing Education information on IPCE credits.

    Why is this webinar important to you? 
    This webinar will present a case study that describes the impact on bleeding rates of two different strategies for transitioning from a direct oral anticoagulant (DOAC) to a parenteral anticoagulant: a delayed, clinically-driven strategy versus the standard per-package-insert strategy. Learners that complete this course will be able to discuss current recommendations for transitioning between DOACs and parenteral anticoagulation and to explore evidence on alternative strategies which may be beneficial in select patient populations. Learners will also have a broader understanding of the growing challenges and potential solutions of DOAC management in acutely-ill patients.

    Target Audience
    Interprofessional team of Physicians, Pharmacists, PhDs, Nurse Practitioners and Physician Assistants.

    Learning Objectives
    After completing this activity, the learner will be able to: 

    1) Evaluate literature which contributed to current recommendations for transitioning from DOACs to parenteral anticoagulation;
    2) Analyze new evidence on alternative transition strategies in patients with heightened risk for DOAC accumulation;
    3) Assess the need for future research to provide more definitive guidance on DOAC management in the inpatient setting.

    To receive credit, learners must attend the complete live webinar or view the complete on-demand webinar; complete a post-course assessment and evaluation.


    Chelsea N. Lopez, PharmD, BCCCP

    Clinical Specialist

    Houston Methodist Hosp

    Dr. Chelsea N. Lopez completed her Bachelor of Science in Neurobiology from The Univ of Texas at Austin in 2014. She graduated from the Univ of Illinois - Chicago Coll of Pharmacy with a Doctorate of Pharmacy in 2018. She then completed her PGY1 Pharmacy Practice Residency and PGY2 Critical Care Residency at Houston Methodist Hosp and is now practicing in their Surgical-Liver ICU. Her research interests include anticoagulation strategies, management of patients with mechanical circulatory support devices, transfusion optimization in cirrhotic patients and medication dosing in continuous renal replacement therapy. 

  • 2021 ACCP Webinar | Communicating Your Science: Acing Presentations & Posters at Conferences-ON DEMAND

    Contains 4 Component(s), Includes Credits

    During this webinar, attendees that complete this event will expand their skill set to publish scientific manuscripts and expand written communication abilities.

    2021 ACCP Webinar - Communicating Your Science: Acing Presentations & Posters at Conferences- ON DEMAND

    Live webinar: May 12, 2021 from 2:00 - 3:30 PM ET 

    On-demand webinar recording:  May 12, 2021 to May 12, 2024

    Why is this article important to your practice? 

    Effective presentation and communication of your scientific research are critical skills for any scientist in the field of clinical pharmacology. This often-overlooked skill set can be challenging to develop and become an expert in; however, with a few tried and true strategies, you can effectively communicate your science and impress your audience. In this webinar, Speakers will walk Attendees through some effective strategies on how to present your research at virtual and in-person educational events, implementation of innovative poster designs and tools to stand out from the crowd at your next conference.

    Target Audience:

    Interprofessional team of Physicians and Pharmacists, especially Student, Trainees & Early-stage Professionals.

    Learning Objectives: 

    After completing this activity, the learner will be able to:

    1. Recognize different formats in which scientific results can be presented at a conference (Abstract, Poster, Podium Presentation, Seminar) and the step-wise process to create the necessary Abstract/Poster to present your research in the field of clinical pharmacology;
    2. Learn the process and key steps of picking a conference to which you should submit an Abstract/Poster for presentation, as well as the process of creating an engaging presentation of scientific work to communicate your research to the scientific community;
    3. Demonstrate newly gained knowledge of the process of creating an Abstract/Poster, as well as writing, reviewing, editing and submitting an Abstract/Poster for presentation at a conference in order to improve the likelihood of acceptance and provide a high-quality Poster or presentation.

    To receive credit, learners must attend the complete live webinar or view the complete on-demand webinar; complete a post-course assessment and evaluation.



    Matthew B. Dufek, PhD

    Sr Director of Clinical Development – Neuroscience Therapeutic Area

    Dr. Dufek completed his graduate training at the Univ of North Carolina at Chapel Hill and is currently Sr Director of Clinical Development – Neuroscience Therapeutic Area at AbbVie Inc in Chicago, IL. For over 20 years, Dr. Dufek has worked at several small biotechnology as well as large pharmaceutical companies. Joining AbbVie in 2012, he currently holds a position as a Director of Clinical Development in the Dept of Clinical Pharmacology & Pharmacometrics where he helps lead the clinical pharmacology & clinical development strategy/team for the development of new pharmaceutical therapies as well as supporting a diverse portfolio of marketed products. These projects have included supporting therapeutic areas of pulmonary medicine, immunology, men’s & women’s health, anti-infective (HIV, RSV and HCV), oncology, renal and pediatrics therapies. Dr. Dufek has an interest and has lectured at many conferences throughout the world as a leading expert in the development of novel approaches for pediatric drug development.

    Alexander Prokopienko, PharmD, PhD

    Clinical Pharmacologist

    Dr. Prokopienko graduated from Albany College of Pharmacy with his PharmD and subsequently from the Univ of Pittsburgh with his PhD in Clinical Pharmaceutical Sciences. During his PhD, Alex was selected as a recipient of the AFPE Pre-Doctoral fellowship, NIH TL1 Post-Doctoral fellowship and NIH Clinical Research Loan Repayment Program. After completing his PhD, he joined Vertex Pharmaceuticals as a Clinical Pharmacologist. 

  • 2021 ACCP Journal of Clinical Pharmacology Journal CE | Monthly CE Offerings

    Contains 40 Component(s), Includes Credits

    The American College of Clinical Pharmacology® monthly journal article continuing education offerings from The Journal of Clinical Pharmacology.

    Registration and Pricing

    The American College of Clinical Pharmacology® (ACCP) offers a monthly article from the The Journal of Clinical Pharmacology (JCP) for continuing education credit. See the CE Info tab for more information on credits. The ACCP JCP Journal CE articles are priced and packaged for January through December of the same calendar year. Packages are available at no cost to ACCP Members and $75/calendar year to Non-members. Once registered, learners have access to all of the Journal CE articles for the calendar year as the articles are released.

    To register, log into your ACCP online profile and then register by clicking the green Register button at the top right. Follow the online prompts to complete the registration process and to receive your registration confirmation. If you do not have an ACCP profile, one must be created before you can register for the Journal CE articles. If you do not know if you have a profile, please contact KLevy@ACCP1.org for further information to avoid creating duplicate profiles. Please address all other questions to CE@ACCP1.org.

    Requirements for Credits

    All requirements for claiming CE credits are listed in the CE Info tab. Continuing education credits and certificates must be claimed within 30-days of completing the monthly article offering. Continuing Pharmacy Education (CPE) data is uploaded into the CPE Monitor at the end of each month. The pharmacist's NABP# and MMDD of birth must be updated into their ACCP Profile or emailed to CE@ACCP1.org in order to have CPE credits automatically uploaded to the CPE Monitor.

    CE Expiration 12/31/2023




     

  • 2021 ACCP Virtual Journal Club March | Discordance between Child Pugh and National Cancer Institute Classifications for Hepatic Dysfunction: Implications for Dosing Recommendations of Oncology Compounds - ON DEMAND

    Contains 5 Component(s), Includes Credits

    Presented by: Mohamed Elmeliegy, PhD

    Discordance Between Child-Pug and National Cancer Institute Classifications for Hepatic Dysfunction: Implications on Dosing Recommendations for Oncology Compounds- ON DEMAND

    ACCP Virtual Journal Club Webinars

    Live Session: Wednesday, March 17, 2021 from 2:00-3:00 PM ET

    On Demand: March 17, 2021 to March 17, 2024

    See Handouts tab for Continuing Education information on IPCE credits.